NCT01929577View on ClinicalTrials.gov

A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Bioavailability of ASP015KHealthy SubjectsPharmacokinetics of ASP015KFood Effect of ASP015K

Interventions

DRUG

ASP015K

oral tablet

Trial Locations (1)

21225

Parexel - Early Phase Clinical Unit, Baltimore

Sponsors

Collaborators (1)

Janssen Biotech, Inc.

All Listed Sponsors

collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01929577 - A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter